Dichloroacetate sodium (DrugBank: Dichloroacetate)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 86 | Pulmonary arterial hypertension | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01083524 (ClinicalTrials.gov) | March 2010 | 8/3/2010 | Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension | A Phase I, Open-Label, Two Centre Study to Evaluate Dichloroacetate(DCA) in Advanced Pulmonary Arterial Hypertension. | Pulmonary Hypertension (Idiopathic, Familial or Anorexigen-associated) | Drug: Dichloroacetate Sodium | University of Alberta | Imperial College London | Completed | 18 Years | N/A | Both | 30 | Phase 1 | Canada;United Kingdom |